(CRVS) Corvus Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Corvus Pharmaceuticals | (CRVS) share price targets
Complete technical analysis of Corvus Pharmaceuticals (CRVS) by charts plus indicators, forecast predictions and share price targets for Corvus Pharmaceuticals (CRVS)
Corvus Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2025-11-05 View latest technical analysis
10 day averaged volume of Corvus Pharmaceuticals is 1151221
| Date | Daily Closing Price | Open | High | Low | Volume |
| 05 Wed Nov 2025 | 7.53 | 7.54 | 7.96 | 7.13 | 1.365 times |
| 04 Tue Nov 2025 | 7.64 | 7.40 | 7.66 | 7.33 | 1.048 times |
| 31 Fri Oct 2025 | 8.04 | 7.76 | 8.44 | 7.50 | 1.638 times |
| 31 Fri Oct 2025 | 8.04 | 7.76 | 8.44 | 7.50 | 1.638 times |
| 30 Thu Oct 2025 | 7.76 | 7.68 | 8.05 | 7.60 | 1.159 times |
| 29 Wed Oct 2025 | 7.68 | 7.74 | 7.87 | 7.46 | 0.656 times |
| 28 Tue Oct 2025 | 7.59 | 7.78 | 7.80 | 7.51 | 0.58 times |
| 27 Mon Oct 2025 | 7.86 | 7.42 | 7.96 | 7.40 | 1.224 times |
| 24 Fri Oct 2025 | 7.35 | 7.25 | 7.63 | 7.20 | 0.978 times |
| 23 Thu Oct 2025 | 7.14 | 6.92 | 7.41 | 6.92 | 0.321 times |
My analysis of stock is bullish for shortterm, and stock might move up till 7.8 or till 8.2. Use a stoploss of 7.45 and if this stock hits its stoploss, then it can fall down till 7.12
Share price targets for Corvus Pharmaceuticals (CRVS)
| Target Type | Value |
| Downside Target | 3.71 |
| Downside Target | 3.96 |
| Downside Target | 4.98 |
| Downside Target | 5.58 |
| Downside Target | 5.81 |
| Downside Target | 6.39 |
| Downside Target | 6.81 |
| Downside Target | 7.13 |
| Downside Target | 7.40 |
| Upside Target | 7.96 |
| Upside Target | 7.98 |
| Upside Target | 8.44 |
Intraday share price targets for Corvus Pharmaceuticals (CRVS)
| Target Type | Value |
| Downside Intraday Target | 7.12 |
| Downside Intraday Target | 6.71 |
| Upside Intraday Target | 7.95 |
| Upside Intraday Target | 8.37 |
| Upside Intraday Target | 7.54 |
Weekly technical analysis of Corvus Pharmaceuticals (CRVS)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 05 Wed Nov 2025 | 7.53 | 7.40 | 7.96 | 7.13 | 1.473 times |
| 31 Fri Oct 2025 | 8.04 | 7.76 | 8.44 | 7.50 | 0.312 times |
| 31 Fri Oct 2025 | 8.04 | 7.42 | 8.44 | 7.40 | 1.598 times |
| 24 Fri Oct 2025 | 7.35 | 7.04 | 7.63 | 6.81 | 0.605 times |
| 17 Fri Oct 2025 | 6.94 | 7.27 | 7.98 | 6.81 | 1.279 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Corvus Pharmaceuticals (CRVS)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 05 Wed Nov 2025 | 7.53 | 7.40 | 7.96 | 7.13 | 0.107 times |
| 31 Fri Oct 2025 | 8.04 | 7.38 | 8.44 | 6.39 | 1.711 times |
| 30 Tue Sep 2025 | 7.37 | 5.64 | 7.45 | 5.58 | 1.368 times |
| 29 Fri Aug 2025 | 5.74 | 4.10 | 5.81 | 3.96 | 1.002 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Corvus Pharmaceuticals (CRVS)
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Corvus Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Corvus Pharmaceuticals in short term but the sell signal is initial and weak.
Corvus Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Corvus Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Corvus Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 7.75 and Corvus Pharmaceuticals (CRVS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Corvus Pharmaceuticals (CRVS) stock. Volume based technical analysis of Corvus Pharmaceuticals (CRVS) stock is negative.
Corvus Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Corvus Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Corvus Pharmaceuticals in short term but the sell signal is initial and weak.
Corvus Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Corvus Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Corvus Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 7.75 and Corvus Pharmaceuticals (CRVS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Corvus Pharmaceuticals (CRVS) stock. Volume based technical analysis of Corvus Pharmaceuticals (CRVS) stock is negative.
Corvus Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.